HIGHLIGHTS
- who: Eiichiro Kanda from the Department of Science, Kawasaki School, Matsushima, Kurashiki, Okayama, u20110192, Japan at the University of California Los Angeles, Los Angeles, CA, USA have published the article: Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia, in the Journal: (JOURNAL)
- what: This study provides a direct comparison of the impact of maintained versus down-titrated or discontinued RAASi regimens (including, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers , angiotensin receptor-neprilysin inhibitors , and mineralocorticoid receptor antagonists ) on cardiorenal risk following an episode of HK in patients with HF and/or CKD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.